The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials.

The effect of selegiline in the treatment of people with Alzheimer's disease: a meta-analysis of published trials.

OBJECTIVE: To evaluate the effect of selegiline in the treatment of patients with Alzheimer's disease, in terms of cognitive performance, functional ability, emotional state (including behaviour and mood) and global response. Data Sources The Cochrane database of trials, Embase, Medline and Ps...

Full description

Bibliographic Details
Main Authors:	Wilcock, G, Birks, J, Whitehead, A, Evans, S
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease
by: Wilcock, G, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Pratt, R, et al.
Published: (2001)

Donepezil: A meta-analysis of individual patient data from randomized controlled trials in the treatment of patients with mild to moderate Alzheimer's disease.
by: Perdomo, C, et al.
Published: (2003)

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.
by: Whitehead, A, et al.
Published: (2004)

Effect of Combined Electroacupuncture and Selegiline Treatment in Alzheimer’s Disease: An Animal Model
by: Mudan Cai, et al.
Published: (2020-12-01)

Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis
by: Ke Wang, et al.
Published: (2023-04-01)

Evidence-based pharmacotherapy of Alzheimer's disease.
by: Evans, J, et al.
Published: (2004)

Velnacrine for Alzheimer's disease.
by: Birks, J, et al.
Published: (2004)

A comparison between Bromocriptine and Selegiline in treatment of Parkinsons disease
by: A Ahmadi Ahangar, et al.
Published: (2002-07-01)

Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration.
by: Qizilbash, N, et al.
Published: (1998)

Treatment for Alzheimer's disease.
by: Wilcock, G
Published: (2000)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

Selegiline in Comparison with Methylphenidate in Treatment of Adults with Attention Deficit yperactivity Disorder: A Double-blind, Randomized Trial
by: Farbod Fadai, et al.
Published: (2009-12-01)

Chemoenzymatic Synthesis of Selegiline: An Imine Reductase-Catalyzed Approach
by: Yuliang Hu, et al.
Published: (2024-03-01)

Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
by: Laszlo G. Harsing, et al.
Published: (2023-08-01)

In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer’s Disease
by: Huang ST, et al.
Published: (2024-01-01)

Treatment of the cholinergic impairment in Alzheimer's disease
by: Wilcock, G
Published: (1994)

Current approaches to the treatment of Alzheimer's disease.
by: Wilcock, G
Published: (1996)

Effect of Selegiline on Pituitary- Gonad Axis and Spermatogenesis in Adult Male Rats
by: Mokhtar Mokhtari, et al.
Published: (2005-06-01)

Selegiline improves excessive daytime sleepiness in Parkinson's disease: an open-label observational study
by: Jinru Zhang, et al.
Published: (2022-07-01)

Treatment of Alzheimer's disease: future directions.
by: Wilcock, G, et al.
Published: (1996)

Effects of Subchronic Treatment With Selegiline on L-DOPA-Induced Increase in Extracellular Dopamine Level in Rat Striatum
by: Adachi Kouichi, et al.
Published: (2006-01-01)

Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
by: Judit Szepesy, et al.
Published: (2021-03-01)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
by: Wilcock, G
Published: (2007)

Adjuvant potential of selegiline in attenuating organ dysfunction in septic rats with peritonitis.
by: Cheng-Ming Tsao, et al.
Published: (2014-01-01)

Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis.
by: de Jager, C, et al.
Published: (2010)

Drug treatment of Alzheimer's disease - a clinician's view point
by: Wilcock, G
Published: (1991)

Selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report
by: Kitaichi Y, et al.
Published: (2013-10-01)

Effect of selegiline on neural stem cells differentiation: a possible role for neurotrophic factors
by: Kambiz Hassanzadeh, et al.
Published: (2015-06-01)

Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice
by: Cornel Chiriță, et al.
Published: (2019-10-01)

Neurotrophins in Alzheimer's disease
by: Wilcock, G
Published: (2002)

Disease-modifying treatments for Alzheimer's disease: a perspective based on experience with R-Flurbiprofen.
by: Wilcock, G
Published: (2006)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
by: Wilcock, G, et al.
Published: (1993)

The effects of galantamine treatment on caregiver time in Alzheimer's disease.
by: Sano, M, et al.
Published: (2003)

Disease-modifying trials in Alzheimer's disease: a European task force consensus.
by: Vellas, B, et al.
Published: (2007)

Effects of (-)deprenyl (selegiline) on acetylcholinesterase and Na(+),K(+)-ATPase activities in adult rat whole brain.
by: Antoniades, C, et al.
Published: (2002)

Alzheimer's disease--current issues.
by: Wilcock, G
Published: (1988)

TACRINE AND LECITHIN IN ALZHEIMERS-DISEASE
by: Wilcock, G
Published: (1990)

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
by: Hidetomo Murakami, et al.
Published: (2017-09-01)

Hyperinsulinaemia and Alzheimer's disease.
by: Razay, G, et al.
Published: (1994)